Single-blind randomized clinical trial in premature infants with Respiratory Distress Syndrome (RDS) eligible for treatment with exogenous surfactant identified early by lung ultrasonography.

Status

Not yet recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-515641-42-00

Enrollment

Registered

2024-06-26

Start date

Unknown

Completion date

Unknown

Last updated

2025-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature infants with Respiratory Distress Syndrome (RDS)

Brief summary

Intubation rate in the next 72 hours of life.

Interventions

DRUGCurosurf

DRUG240 mg/3 ml

DRUGsuspensão para instilação endotraqueobrônquica

Eligibility

Sex/Gender

All

Age

0 Years to 17 Years

Design outcomes

Primary

Measure	Time frame
Intubation rate in the next 72 hours of life.	—

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026